Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma

INTRODUCTION: Hypercalcemia of malignancy (HCM) portends a very poor prognosis, and no established guidelines exist regarding its management. Most instances of HCM are due to local osteolysis or secretion of parathyroid hormone related-peptide, while less than 1% of all cases are due to ectopic secr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroopnick, Jeffrey M., Martinez-Outschoorn, Ubaldo, Tuluc, Madalina, Kim, Caroline S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165115/
https://www.ncbi.nlm.nih.gov/pubmed/34095488
http://dx.doi.org/10.1016/j.aace.2021.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165115/
https://www.ncbi.nlm.nih.gov/pubmed/34095488
http://dx.doi.org/10.1016/j.aace.2021.01.003

Ejemplares similares